Coverage
-
January 24, 2023
The First Circuit on Monday revived medical device maker Conformis Inc.'s trade libel claims against Aetna Inc., finding that the insurer's policy claim that the company's knee implants were "experimental" and "investigational" can plausibly be considered actionable product disparagement.
2 other articles on this case.
View all »